TY - JOUR
T1 - Synthesis and biological properties of new 2β-alkyl- and 2β-aryl-3- (substituted phenyl)tropane derivatives
T2 - Stereochemical effect of C-3 on affinity and selectivity for neuronal dopamine and serotonin transporters
AU - Kozikowski, Alan P.
AU - Araldi, Gian Luca
AU - Prakash, K. R.C.
AU - Zhang, Mei
AU - Johnson, Kenneth M.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1998/12/3
Y1 - 1998/12/3
N2 - In our efforts to identify molecules that might act as cocaine antagonists or cocaine partial agonists, we have been involved in efforts to further elucidate the nature of cocaine's binding to the dopamine transporter (DAT) through strategic modifications of its structure. In the case of the substituent located at the 2-position of the tropane ring, studies have revealed the ability of the transporter to accommodate groups of diverse structure, including ester, ketone, alkyl, alkenyl, heterocyclic, and aryl substituents, without loss of DAT binding affinity. In the present study, we report our results pertaining to the ability of the DAT to accommodate the WIN-type structures possessing alkyl or aryl groups at the 2-position and which adopt either a chair or a boat conformation of the tropane ring. Moreover, we discuss the influence of the stereochemistry of these compounds in their selectivity for the DAT versus the serotonin transporter (5HTT). Additionally, we point out the importance of using K(i) values rather than IC50 values when making such comparisons of transporter selectivity. One of the most interesting compounds identified in the present work is a 2,3- diaryltropane 22 in a boat conformation that is highly selective (69-fold) for the DAT over the-5HTT. The ability to prepare this compound as well as related structures by our oxidopyridinium betaine-based dipolar cycloaddition strategy further underscores the versatility of this particular chemical approach to the preparation of diverse tropane analogues. The use of the optically pure olefin p-tolyl vinyl sulfoxide as the dipolarophile in this reaction allows access to these novel tropanes in nonracemic form.
AB - In our efforts to identify molecules that might act as cocaine antagonists or cocaine partial agonists, we have been involved in efforts to further elucidate the nature of cocaine's binding to the dopamine transporter (DAT) through strategic modifications of its structure. In the case of the substituent located at the 2-position of the tropane ring, studies have revealed the ability of the transporter to accommodate groups of diverse structure, including ester, ketone, alkyl, alkenyl, heterocyclic, and aryl substituents, without loss of DAT binding affinity. In the present study, we report our results pertaining to the ability of the DAT to accommodate the WIN-type structures possessing alkyl or aryl groups at the 2-position and which adopt either a chair or a boat conformation of the tropane ring. Moreover, we discuss the influence of the stereochemistry of these compounds in their selectivity for the DAT versus the serotonin transporter (5HTT). Additionally, we point out the importance of using K(i) values rather than IC50 values when making such comparisons of transporter selectivity. One of the most interesting compounds identified in the present work is a 2,3- diaryltropane 22 in a boat conformation that is highly selective (69-fold) for the DAT over the-5HTT. The ability to prepare this compound as well as related structures by our oxidopyridinium betaine-based dipolar cycloaddition strategy further underscores the versatility of this particular chemical approach to the preparation of diverse tropane analogues. The use of the optically pure olefin p-tolyl vinyl sulfoxide as the dipolarophile in this reaction allows access to these novel tropanes in nonracemic form.
UR - http://www.scopus.com/inward/record.url?scp=0032480909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032480909&partnerID=8YFLogxK
U2 - 10.1021/jm9802564
DO - 10.1021/jm9802564
M3 - Article
C2 - 9836615
AN - SCOPUS:0032480909
SN - 0022-2623
VL - 41
SP - 4973
EP - 4982
JO - Journal of medicinal chemistry
JF - Journal of medicinal chemistry
IS - 25
ER -